Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 142.88 |
| Open | 142.12 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's Range | 141.25 - 143.94 |
| 52 Week Range | 75.56 - 143.94 |
| Volume | |
| Avg. Volume | 3,899,825 |
| Market Cap | 639.767B |
| Beta (5Y Monthly) | 0.17 |
| PE Ratio (TTM) | 49.53 |
| EPS (TTM) | 2.90 |
| Earnings Date | Aug 07, 2024 |
| Forward Dividend & Yield | 1.37 (0.95%) |
| Ex-Dividend Date | Mar 22, 2024 |
| 1y Target Est | 151.40 |
Yahoo FinanceEli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
Investor's Business DailyMeet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
© 2024 Yahoo. All rights reserved.